| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.2M | +29.1% |
| R&D Expense | $30.8M | +14.8% |
| SG&A Expense | $22.0M | +20.7% |
| Operating Income | -$38.6M | +37.8% |
| Pre-tax Income | -$49.6M | +13.8% |
| Income Tax | $0 | — |
| Net Income | -$49.6M | +13.8% |
| EPS (Basic) | -$0.80 | +62.8% |
| EPS (Diluted) | -$0.80 | +62.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.1M | +48.7% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $2.0M | -44.0% |
| Current Assets | $50.0M | +36.7% |
| Total Assets | $50.2M | +36.3% |
| Current Liabilities | $7.8M | -31.1% |
| Long-term Debt | $1.1M | — |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.3M | -37.8% |
| Investing Cash Flow | $0 | -100.0% |
| Financing Cash Flow | $50.0M | +1095.0% |
| $34.9M |
| +208.9% |
| Stockholders' Equity | $15.3M | +128.3% |